Related article: Birth control, Palliative vs. curative treatments
Related article: Birth control, Palliative vs. curative treatments
Due to the nature of chronic disease, it is common for female patients suffering from chronic diseases to have low levels of the female hormones.
When supplemented, all of the steroid hormones, including the female hormones, have the capacity to interfere with the proper function of various nuclear receptors. This effect is dose-dependent. Marshall Protocol (MP) patients are advised to work with their doctor to use the lowest dose of medication that is effective.
Main article: Hormone and pro-hormone therapy
Related article: Palliative vs. curative treatments
Due to the nature of chronic disease, it is common for patients suffering from chronic diseases to have low levels of hormones. This is often due to high levels of the vitamin D metabolite 1,25-DPrimary biologically active vitamin D hormone. Activates the vitamin D nuclear receptor. Produced by hydroxylation of 25-D. Also known as 1,25-dihydroxycholecalciferol, 1,25-hydroxyvitamin D and calcitirol. which interferes with the production of hormones such as T3, testosterone, etc. Because the vitamin D system is dysregulated in chronically ill patients, supplementing with other hormones tends to further dysregulate the receptors rather than increase hormonal expression. Thus, hormone supplementation is contraindicated. If the patient is already on hormone “replacement” therapy, judicious use of low-dose hormone therapy (to relieve intolerable symptoms) may be necessary until the patient is able to wean from the hormones.
Marshall Protocol (MP) patients are advised to work with their doctor to use the lowest dose of medication that is effective.
As patients begin to kill the Th1 pathogensThe community of bacterial pathogens which cause chronic inflammatory disease - one which almost certainly includes multiple species and bacterial forms. causing their disease, vitamin D metabolism restabilizes and 1,25-D's effects on hormonal stabilization becomes less of an issue. Once this happens, there is no longer a need to take extra hormone supplements, and patients can then wean off their steroids.
I used a bioidentical topical hormone cream for several years which worked great for my menopause symptoms. But when Dr. Marshall's molecular modeling work showed that there could be competition between these hormones and Benicar for the VDR, I decided to wean off the cream. This was no fun at all! But I'm glad I did it.
Carol